For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and the formulated version represents a true change. These novel therapies stabilize the transthyretin protein, halting its damaging build-up and alleviating the impact of the condition . People are now reporting improv